KRAS and pancreatic neoplasm: The expression of NOP56 in KRAS mutant pancreatic cancer cell lines (MIAPaCa, HPAF-II) and colon cancer cell lines (HCT-116, DLD-1) is significantly higher than that in KRAS wild-type tumor cell lines (46).